Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ·Healthcare·Biotechnology
$9.40
+5.33%
Mkt Cap $119.71M
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (15 analysts)
$38.50
Range $33.00 – $44.00
Implied Upside
+309.8%
Consensus $38.50 vs current $9.40